After rebounding from the March 2025 lows, the Nifty50 has regained upward momentum. According to smallcase managers, the ...

Indian stock market benchmarks—the Sensex and the Nifty 50—ended lower on Friday, 18 July, extending losses for the third ...

With the stock currently trading at Rs 1,954.90, Gland Pharma faces a challenging trading environment amidst early market volatility.

Technical indicators for the Nifty 50 suggest caution. The index closed at 24,968 on Friday, forming a bearish candle on the ...

India's stock market exhibits calmness as the Volatility Index hits a 15-month low, reflecting stability and reduced risk ...

Markets open cautiously, Sensex and Nifty decline, FII selling continues, technical analysis indicates short-term weakness, ...

The Indian rupee and local equities have been increasingly moving in sync over the past month as muted portfolio flows alongside lingering uncertainty over U.S. tariffs continue to cloud investor ...

The Indian stock market opened on a weak note on Friday amid tepid quarterly earning session. Reliance Industries Limited ...

Axis Securities has suggested a Bear Put Spread strategy for Nifty options contracts expiring on 24 July 2025, reflecting a moderately bearish outlook.

PL Capital predicts India's Nifty 50 index could reach a record 28,957 by December 2025 in a bullish scenario. Their base case target is 26,889, while the bear case projects 24,821.

On Tuesday, 15 July, the Indian stock market showed remarkable resilience as it clawed back intraday losses to close on a ...